1. sunbet(中国)

        Proliferation assay

        Philippa R Kennedy

        Published: 2022-09-02 DOI: 10.17504/protocols.io.261geojwol47/v1
        AI 解读
        浏览 1399

        Abstract

        Assessing the impact of drugs and treatments on natural killer (NK) cell viability and expansion.

        Steps

        1.

        PBMCs or enriched NK cells (see Isolating NK cells from human blood products ) are labeled with a permanent amine-reactive dye (CellTrace Violet Proliferation Kit, Cat. No:C34557, Thermo Fisher) according to the manufacturer's instructions.

        2.

        Cells are exposed to various experimental conditions, then harvested after 7 days of culture.

        3.

        Optional: If required, cells can be stained for apoptotic markers (FITC Annexin V, Cat. No: 556419, BD Biosciences) according to the manufacturer's instructions prior to antibody staining.

        4.

        Cells are stained with a dead cell marker (LIVE/DEAD NEAR-IR, Cat. No: L34976, Thermo Fisher), PE-CY7 conjugated anti-CD56 (HCD56, BioLegend), and PE-CF594 conjugated anti-CD3 (UCHT1, BD BioSciences).

        5.

        The samples are run on a flow cytometer (LSRII, BD Biosciences) and analyzed using FlowJo software (Tree Star Inc., RRID:SCR_008520).

        The proliferation of live (dead cell marker- and annexin V-) NK cells (CD56+/CD3-) and T cells (CD56-/CD3+) is assessed by dilution of the dye.

        Relative numbers of live NK cells and T cells for each treatment condition are obtained by running the flow cytometer at a constant flow rate and analyzing the number of each cell type obtained within a specified time limit e.g. 60s.

        推荐阅读

        Nature Protocols
        Protocols IO
        Current Protocols
        扫码咨询